FDA Inspection 711115 — Sangamo Therapeutics, Inc
The FDA completed an inspection of Sangamo Therapeutics, Inc on March 7, 2011 in Richmond, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- March 7, 2011
- Fiscal Year
- 2011
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Richmond, CA (United States)
Additional Details
Sponsor, Contract Research Organization